Background Long-term cancer control outcomes in clinically high-risk prostate cancer (PCa)
patients treated with robot-assisted radical prostatectomy (RARP) remain unknown …

High-risk prostate cancer (HR Pca) is a highly heterogeneous disease from a biological and
clinical standpoint, and it carries a significant chance of morbidity and mortality. Despite the …

Background Some high-risk prostate cancer (PCa) patients may show more favorable
Gleason pattern at radical prostatectomy (RP) than at biopsy. Objective To test whether …

Background: In high-risk prostate cancer (HR-PCA), it is important to consider the factors
associated with extensive lymph node invasion (LNI) before planning treatment methods …

We aimed to externally validate the SEER-based nomogram used to predict downgrading in
biopsied high-risk prostate cancer patients treated with radical prostatectomy (RP) in a …

Objectives To verify retrospectively the margin status and analyse the location and
characteristics of positive surgical margins (PSM s) in patients undergoing radical …

Objective High-dose-rate (HDR) brachytherapy boost represents a method to dose escalate
in high-risk prostate cancer; the purpose of this analysis is to report long-term outcomes for a …

Purpose To evaluate the better risk stratification based on surgical pathology, and to predict
oncologic outcomes after radical prostatectomy (RP) with a better scoring system in high-risk …

The presence of lymph node involvement represents a greater risk of disease progression,
recurrence and death in patients with prostate cancer. Lymphadenectomy is integrated into …